Home
/
PAVmed Inc.
/
Financials
/
Quarterly
PAVmed Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PAVmed Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$1.00M
Nov 14, 2024
Q2
2024
Jun 30, 2024
$1.00M
Aug 12, 2024
Q1
2024
Mar 31, 2024
$1.00M
May 13, 2024
Q3
2022
Sep 30, 2022
$189.0K
Nov 14, 2022
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.0K
Nov 12, 2025
Q2
2025
Jun 30, 2025
$6.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$8.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$996.0K
Nov 12, 2025
Q2
2025
Jun 30, 2024
$979.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$1.01M
May 15, 2025
Q3
2024
Sep 30, 2023
$791.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$166.0K
Aug 12, 2024
Q1
2024
Mar 31, 2023
$446.0K
May 13, 2024
Q3
2023
Sep 30, 2022
$76.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$189.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$189.0K
May 15, 2023
Q3
2022
Sep 30, 2021
$200.0K
Nov 14, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.38M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($11.92M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
$18.97M
May 15, 2025
Q3
2025
Sep 30, 2024
$64.40M
Nov 12, 2025
Q2
2025
Jun 30, 2024
($10.83M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($15.21M)
May 15, 2025
Q3
2024
Sep 30, 2023
($17.67M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($14.54M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($17.93M)
May 13, 2024
Q3
2023
Sep 30, 2022
($26.13M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($25.53M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($16.87M)
May 15, 2023
Q3
2022
Sep 30, 2021
($12.23M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($11.47M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($9.43M)
May 16, 2022
Q3
2021
Sep 30, 2020
($5.48M)
Nov 22, 2021
Q2
2021
Jun 30, 2020
($5.58M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($14.48M)
May 17, 2021
Q3
2020
Sep 30, 2019
($3.09M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($3.59M)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.84M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($4.72M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($5.45M)
May 15, 2025
Q3
2025
Sep 30, 2024
($11.58M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($13.68M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($14.04M)
May 15, 2025
Q3
2024
Sep 30, 2023
($15.53M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($16.48M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($20.40M)
May 13, 2024
Q3
2023
Sep 30, 2022
($23.37M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($23.48M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($19.64M)
May 15, 2023
Q3
2022
Sep 30, 2021
($13.67M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($12.97M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($8.08M)
May 16, 2022
Q3
2021
Sep 30, 2020
($5.53M)
Nov 22, 2021
Q2
2021
Jun 30, 2020
($5.01M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($5.25M)
May 17, 2021
Q3
2020
Sep 30, 2019
($3.24M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($3.32M)
Aug 14, 2020